Gandhar Oil Refinery (India) Ltd – Q3 FY26 ₹1,167 Cr quarterly revenue, 67.6% PAT jump, yet ROE stuck at single digits


1. At a Glance – “Looks Global, Earns Local Returns”

Gandhar Oil Refinery (India) Ltd, currently chilling at ₹163, carries a market cap of ₹1,588 Cr, trades at a P/E of ~14.9, and pretends to be a global FMCG ingredient supplier while behaving financially like a mid-cycle commodity refiner on most days.

Latest quarter (Q3 FY26) came in hot:

  • Revenue: ₹1,167 Cr (+16.1% YoY)
  • PAT: ₹34.3 Cr (+67.6% YoY)
  • OPM: 5%
  • EPS (Q3): ₹3.31

Stock is up 19.1% in 3 months, but still down ~15% YoY, which tells you markets are confused, not convinced.

Exports form 85% of revenue, customers span 100+ countries, and yet ROCE is 10.6% and ROE is just 6.65%. That’s not luxury skincare economics, that’s bulk chemicals with a marketing filter.

So the big question:
👉 Is Gandhar a misunderstood global niche champion… or just a volume-led refiner with good passport stamps?

Let’s dissect.


2. Introduction – The Vaseline Economy

Gandhar Oil Refinery (India) Ltd was incorporated in 1992 and built its empire quietly—not on crude oil headlines, but on white oils.

White oils are boring.
They don’t explode, don’t stink, don’t trend on Twitter.
But they sit inside:

  • baby oils
  • cosmetic creams
  • OTC pharma
  • petroleum jelly
  • healthcare lubricants

Basically, products where contamination can get you sued into oblivion.

That’s Gandhar’s moat: purity + consistency + regulatory approvals.

India market share in white oils? 26.5%
Global market share? 9.6%
Top 5 globally? ✔️

Sounds sexy.
But then why are margins stuck at 4–6%, ROE mediocre, and cash flows erratic?

Because Gandhar isn’t selling luxury brands.
It’s selling high-volume, low-margin, compliance-heavy oils where scale saves you, but capital efficiency haunts you.

And Gandhar has chosen exports + volume + capacity expansion as religion.

Is that

faith rewarded?
Let’s see.


3. Business Model – WTF Do They Even Do?

A. PHPO – Personal Care, Healthcare & Performance Oils

This is Gandhar’s crown jewel.

  • Contributes 47.1% of total revenue (9M FY25)
  • Used in cosmetics, pharma, OTC, petroleum jelly
  • 69% of PHPO revenue comes from consumer & healthcare

This is where Gandhar dreams of being an ingredient multinational, not just a refiner.

Margins here are better than lubricants, but still not FMCG-level because:

  • B2B pricing
  • Contract manufacturing
  • No brand premium capture

B. Lubricants – The Necessary Evil

  • 28.4% of revenue
  • Auto & industrial oils
  • Cyclical, competitive, price-sensitive

This is the “keep the plants running” segment.

C. PIO – Process & Insulating Oils

  • 9.3% of revenue
  • Transformer oils, rubber processing oils
  • Includes BHEL contract worth ₹24.6 Cr (Aug 2025)

Stable, but not a margin monster.

D. Channel Partners – The Leftover Pie

  • 15.2%
  • Distribution-led, lower control, thinner margins

Question for you:
Would you rather Gandhar chase more PHPO share… or milk lubricants for cash and fund PHPO quietly?


4. Financials Overview – Numbers Without Perfume

EPS Annualisation

Latest quarter EPS (Q3 FY26): ₹3.31
Q3 rule: Average of Q1, Q2, Q3 × 4
But since TTM EPS already exists (₹10.86),

To Read Full 16 Point ArticleBecome a member
Become a member
To Read Full 16 Point ArticleBecome a member

Leave a Comment

error: Content is protected !!